Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Non-Current Debt (2021 - 2024)

Historic Non-Current Debt for HeartSciences (HSCS) over the last 4 years, with Q4 2024 value amounting to $49470.0.

  • HeartSciences' Non-Current Debt changed N/A to $49470.0 in Q4 2024 from the same period last year, while for Oct 2024 it was $49470.0, marking a year-over-year change of. This contributed to the annual value of $500000.0 for FY2023, which is 8874.33% down from last year.
  • Per HeartSciences' latest filing, its Non-Current Debt stood at $49470.0 for Q4 2024.
  • HeartSciences' 5-year Non-Current Debt high stood at $4.4 million for Q2 2022, and its period low was $49470.0 during Q4 2024.
  • For the 4-year period, HeartSciences' Non-Current Debt averaged around $1.0 million, with its median value being $500000.0 (2023).
  • In the last 5 years, HeartSciences' Non-Current Debt surged by 167530.26% in 2022 and then crashed by 8874.33% in 2023.
  • Over the past 4 years, HeartSciences' Non-Current Debt (Quarter) stood at $250200.0 in 2021, then soared by 299.68% to $1.0 million in 2022, then tumbled by 50.0% to $500000.0 in 2023, then plummeted by 90.11% to $49470.0 in 2024.
  • Its Non-Current Debt was $49470.0 in Q4 2024, compared to $500000.0 in Q3 2024 and $500000.0 in Q3 2023.